Synthesis and antibacterial activity of new 7-piperazinylquinolones containing a functionalized 2-(furan-3-yl)ethyl moiety

Archiv der Pharmazie

Volumn 340, Issue 1, 2007, Pages 47-52

  Foroumadi, Alireza ^a   Mohammadhosseini, Negar ^b   Emami, Saeed ^c   Letafat, Bahram ^b   Faramarzi, Mohammad Ali ^a   Samadi, Nasrin ^a   Shafiee, Abbas ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antibacterial activity; Furan; Quinolones; Synthesis

Indexed keywords

2 (FURAN 2 YL) 2 OXOETHYL; 2 (FURAN 2 YL) 2 OXYIMINOETHYL; 7 PIPERAZINYLQUINOLONE DERIVATIVE; CIPROFLOXACIN; ENOXACIN; N [2 (FURAN 3 YL) 2 OXOETHYL]PIPERAZINYLQUINOLONE DERIVATIVE; N [2 (FURAN 3 YL) 2 OXYIMINOETHYL]PIPERAZINYLQUINOLONE DERIVATIVE; NORFLOXACIN; OXIME DERIVATIVE; QUINOLONE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

ANTI-BACTERIAL AGENTS; FURANS; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; PIPERAZINES; QUINOLONES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33846481264     PISSN: 03656233     EISSN: 15214184     Source Type: Journal    
DOI: 10.1002/ardp.200600169     Document Type: Article

References (25)

1. S. Emami, A. Shafiee, A. Foroumadi, Mini-Rev. Med. Chem. 2006, 6, 375-386.
2. H. Koga, A. Itoh, S. Murayama, S. Suzue, T. Irikura, J. Med. Chem. 1980, 23, 1358-1363.
3. L. P. Peterson in Quinolone Antibacterial Agents (Ed.: D. C. Hooper), 2nd ed., American Society for Microbiology, Washington DC, 1993, p. 119.
4. R. C. Moellering in "Quinolone Antimicrobial Agents" (Ed.: D. C. Hooper), 2nd Ed., American Society for Microbiology, Washington DC, 1993, pp. 527-535.
5. V. Cecchetti, A. Fravolini, M. C. Lorenzini, O. Tabarrini, et al., J. Med. Chem. 1996, 39, 436-445.
6. D. C. Hooper, Lancet Infect. Dis. 2002, 2, 530-538.
7. D. T. W. Chu, Annu. Rep. Med. Chem. 1998, 33, 141.
8. Z. Ma, D. T. W. Chu, C. S. Cooper, Q. Li, et al., J. Med. Chem. 1999, 42, 4202-4213.
9. P. C. Appelbaum, P. A. Hunter, Int. J. Antimicrob. Agents 2000, 16, 5-15.
10. G. G. Zhanel, K. Ennis, L. Vercaigne, A. Walkty, et al., Drugs 2002, 62, 13-59.
11. L. L. Shen, L. A. Mitscher, P. N. Sharma, T. J. O'Donnell, et al., Biochemistry 1989, 28, 3886-3894.
12. L. L. Shen, W. E. Kohlbrenner, D. Weigl, J. Baranowski, J. Biol. Chem. 1989, 264, 2973-2978.
13. L. L. Shen, J. Baranowski, A. G. Pernet, Biochemistry 1989, 28, 3879-3885.
14. A. Foroumadi, S. Ghodsi, S. Emami, S. Najjari, et al., Bioorg. Med. Chem. Lett. 2006, 16, 3499-3503.
15. A. Foroumadi, S. Emami, A. Hassanzadeh, M. Rajaee, et al., Bioorg. Med. Chem. Lett. 2005, 15, 4488-4492.
16. A. Foroumadi, R. Ashraf-Askari, M. H. Moshafi, S. Emami, A. Zeynali, Pharmazie 2003, 58, 432-433.
17. A. Foroumadi, S. Mansouri, Z. Kiani, A. Rahmani, Eur. J. Med. Chem. 2003, 38, 851-854.
18. A. Foroumadi, S. Mansouri, S. Emami, J. Mirzaei, et al., Arch. Pharm. 2006, 339, 621-624.
19. A. Foroumadi, S. Emami, P. Haghighat, M. H. Moshafi, Pharm. Pharmacol Commun. 1999, 5, 591-594.
20. T. R. Bailey, Synthesis 1991, 242-243.
21. K. A. Lutomski, U.S. Patent 4,908,357, 1990.
22. S. Emami, A. Shafiee, Heterocycles 2001, 55, 2059-2074.
23. S. Emami, M. Falahati, A. Banifatemi, M. Amanlou, A. Shafiee, Bioorg. Med. Chem. 2004, 12, 3971-3976.
24. S. Emami, M. Falahati, A. Banifatemi, A. Shafiee, Bioorg. Med. Chem. 2004,12, 5881-5889.
25. th Ed., C.V. Mosby, St Louis, 1990, pp. 184-188.